Report copyright - Zebinix (Epilepsy) – Forecast and Market Analysis to 2022 · Zebinix (eslicarbazepine acetate)Sales for Epilepsy by Region, 2012–2022 78% 22% 5EU India 2012 Total:$25.9m 69% 25%
Please pass captcha verification before submit form
Please pass captcha verification before submit form